Click for best price
Autoimmune Drugs Market Size, Share 2022
Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by chronic inflammatory processes that activate the innate immune system and the production of antibodies that destroy host tissues. These inflammatory processes can be caused by genetic or environmental factors or infections.
This report contains market size and forecasts of Autoimmune Drugs in global, including the following market information:
Global top five Autoimmune Drugs companies in 2021 (%)
The global Autoimmune Drugs market was valued at 94140 million in 2021 and is projected to reach US$ 132680 million by 2028, at a CAGR of 5.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Rheumatoid Arthritis (RA) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Autoimmune Drugs include Eli Lilly, GSK, AbbVie, Johnson & Johnson, Biogen, Amgen, Pfizer, Roche and Baxter. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Autoimmune Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Autoimmune Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Autoimmune Drugs Market Segment Percentages, by Type, 2021 (%)
- Rheumatoid Arthritis (RA)
- Multiple Sclerosis (MS)
- Psoriasis
- Inflammatory Bowel Disease (IBD)
- Ankylosing Spondylitis (AS)
- Systemic Lupus Erythematosus (SLE)
Global Autoimmune Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Autoimmune Drugs Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Homecare
- Specialty Clinics
Global Autoimmune Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Autoimmune Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Autoimmune Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Autoimmune Drugs revenues share in global market, 2021 (%)
- Key companies Autoimmune Drugs sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Autoimmune Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Eli Lilly
- GSK
- AbbVie
- Johnson & Johnson
- Biogen
- Amgen
- Pfizer
- Roche
- Baxter
| Report Attributes |
Report Details |
| Report Title |
Autoimmune Drugs Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
72 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Autoimmune Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Autoimmune Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Autoimmune Drugs Overall Market Size
2.1 Global Autoimmune Drugs Market Size: 2021 VS 2028
2.2 Global Autoimmune Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Autoimmune Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Autoimmune Drugs Players in Global Market
3.2 Top Global Autoimmune Drugs Companies Ranked by Revenue
3.3 Global Autoimmune Drugs Revenue by Companies
3.4 Global Autoimmune Drugs Sales by Companies
3.5 Global Autoimmune Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Autoimmune Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Autoimmune Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Autoimmune Drugs Players in Global Market
3.8.1 List of Global Tier 1 Autoimmune Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Autoimmune Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Autoimmune Drugs Market Size Markets, 2021 & 2028
4.1.2 Rheumatoid Arthritis (RA)
4.1.3 Multiple Sclerosis (MS)
4.1.4 Psoriasis
4.1.5 Inflammatory Bowel Disease (IBD)
4.1.6 Ankylosing Spondylitis (AS)
4.1.7 Systemic Lupus Erythematosus (SLE)
4.2 By Type - Global Autoimmune Drugs Revenue & Forecasts
4.2.1 By Type - Global Autoimmune Drugs Revenue, 2017-2022
4.2.2 By Type - Global Autoimmune Drugs Revenue, 2023-2028
4.2.3 By Type - Global Autoimmune Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Autoimmune Drugs Sales & Forecasts
4.3.1 By Type - Global Autoimmune Drugs Sales, 2017-2022
4.3.2 By Type - Global Autoimmune Drugs Sales, 2023-2028
4.3.3 By Type - Global Autoimmune Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Autoimmune Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Autoimmune Drugs Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Homecare
5.1.4 Specialty Clinics
5.2 By Application - Global Autoimmune Drugs Revenue & Forecasts
5.2.1 By Application - Global Autoimmune Drugs Revenue, 2017-2022
5.2.2 By Application - Global Autoimmune Drugs Revenue, 2023-2028
5.2.3 By Application - Global Autoimmune Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Autoimmune Drugs Sales & Forecasts
5.3.1 By Application - Global Autoimmune Drugs Sales, 2017-2022
5.3.2 By Application - Global Autoimmune Drugs Sales, 2023-2028
5.3.3 By Application - Global Autoimmune Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Autoimmune Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Autoimmune Drugs Market Size, 2021 & 2028
6.2 By Region - Global Autoimmune Drugs Revenue & Forecasts
6.2.1 By Region - Global Autoimmune Drugs Revenue, 2017-2022
6.2.2 By Region - Global Autoimmune Drugs Revenue, 2023-2028
6.2.3 By Region - Global Autoimmune Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Autoimmune Drugs Sales & Forecasts
6.3.1 By Region - Global Autoimmune Drugs Sales, 2017-2022
6.3.2 By Region - Global Autoimmune Drugs Sales, 2023-2028
6.3.3 By Region - Global Autoimmune Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Autoimmune Drugs Revenue, 2017-2028
6.4.2 By Country - North America Autoimmune Drugs Sales, 2017-2028
6.4.3 US Autoimmune Drugs Market Size, 2017-2028
6.4.4 Canada Autoimmune Drugs Market Size, 2017-2028
6.4.5 Mexico Autoimmune Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Autoimmune Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Autoimmune Drugs Sales, 2017-2028
6.5.3 Germany Autoimmune Drugs Market Size, 2017-2028
6.5.4 France Autoimmune Drugs Market Size, 2017-2028
6.5.5 U.K. Autoimmune Drugs Market Size, 2017-2028
6.5.6 Italy Autoimmune Drugs Market Size, 2017-2028
6.5.7 Russia Autoimmune Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Autoimmune Drugs Market Size, 2017-2028
6.5.9 Benelux Autoimmune Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Autoimmune Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Autoimmune Drugs Sales, 2017-2028
6.6.3 China Autoimmune Drugs Market Size, 2017-2028
6.6.4 Japan Autoimmune Drugs Market Size, 2017-2028
6.6.5 South Korea Autoimmune Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Autoimmune Drugs Market Size, 2017-2028
6.6.7 India Autoimmune Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Autoimmune Drugs Revenue, 2017-2028
6.7.2 By Country - South America Autoimmune Drugs Sales, 2017-2028
6.7.3 Brazil Autoimmune Drugs Market Size, 2017-2028
6.7.4 Argentina Autoimmune Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Autoimmune Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Autoimmune Drugs Sales, 2017-2028
6.8.3 Turkey Autoimmune Drugs Market Size, 2017-2028
6.8.4 Israel Autoimmune Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Autoimmune Drugs Market Size, 2017-2028
6.8.6 UAE Autoimmune Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Corporate Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Autoimmune Drugs Major Product Offerings
7.1.4 Eli Lilly Autoimmune Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Eli Lilly Key News
7.2 GSK
7.2.1 GSK Corporate Summary
7.2.2 GSK Business Overview
7.2.3 GSK Autoimmune Drugs Major Product Offerings
7.2.4 GSK Autoimmune Drugs Sales and Revenue in Global (2017-2022)
7.2.5 GSK Key News
7.3 AbbVie
7.3.1 AbbVie Corporate Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Autoimmune Drugs Major Product Offerings
7.3.4 AbbVie Autoimmune Drugs Sales and Revenue in Global (2017-2022)
7.3.5 AbbVie Key News
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporate Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Autoimmune Drugs Major Product Offerings
7.4.4 Johnson & Johnson Autoimmune Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Johnson & Johnson Key News
7.5 Biogen
7.5.1 Biogen Corporate Summary
7.5.2 Biogen Business Overview
7.5.3 Biogen Autoimmune Drugs Major Product Offerings
7.5.4 Biogen Autoimmune Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Biogen Key News
7.6 Amgen
7.6.1 Amgen Corporate Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Autoimmune Drugs Major Product Offerings
7.6.4 Amgen Autoimmune Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Amgen Key News
7.7 Pfizer
7.7.1 Pfizer Corporate Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Autoimmune Drugs Major Product Offerings
7.7.4 Pfizer Autoimmune Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Pfizer Key News
7.8 Roche
7.8.1 Roche Corporate Summary
7.8.2 Roche Business Overview
7.8.3 Roche Autoimmune Drugs Major Product Offerings
7.8.4 Roche Autoimmune Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Roche Key News
7.9 Baxter
7.9.1 Baxter Corporate Summary
7.9.2 Baxter Business Overview
7.9.3 Baxter Autoimmune Drugs Major Product Offerings
7.9.4 Baxter Autoimmune Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Baxter Key News
8 Global Autoimmune Drugs Production Capacity, Analysis
8.1 Global Autoimmune Drugs Production Capacity, 2017-2028
8.2 Autoimmune Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Autoimmune Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Autoimmune Drugs Supply Chain Analysis
10.1 Autoimmune Drugs Industry Value Chain
10.2 Autoimmune Drugs Upstream Market
10.3 Autoimmune Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Autoimmune Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Autoimmune Drugs in Global Market
Table 2. Top Autoimmune Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Autoimmune Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Autoimmune Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Autoimmune Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Autoimmune Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Autoimmune Drugs Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Autoimmune Drugs Product Type
Table 9. List of Global Tier 1 Autoimmune Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Autoimmune Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Autoimmune Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Autoimmune Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Autoimmune Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Autoimmune Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Autoimmune Drugs Sales (K Units), 2023-2028
Table 16. By Application ? Global Autoimmune Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Autoimmune Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Autoimmune Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Autoimmune Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Autoimmune Drugs Sales (K Units), 2023-2028
Table 21. By Region ? Global Autoimmune Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Autoimmune Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Autoimmune Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Autoimmune Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Autoimmune Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Autoimmune Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Autoimmune Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Autoimmune Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Autoimmune Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Autoimmune Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Autoimmune Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Autoimmune Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Autoimmune Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Autoimmune Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Autoimmune Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Autoimmune Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Autoimmune Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Autoimmune Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Autoimmune Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Autoimmune Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Autoimmune Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Autoimmune Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Autoimmune Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Autoimmune Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Autoimmune Drugs Sales, (K Units), 2023-2028
Table 46. Eli Lilly Corporate Summary
Table 47. Eli Lilly Autoimmune Drugs Product Offerings
Table 48. Eli Lilly Autoimmune Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. GSK Corporate Summary
Table 50. GSK Autoimmune Drugs Product Offerings
Table 51. GSK Autoimmune Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. AbbVie Corporate Summary
Table 53. AbbVie Autoimmune Drugs Product Offerings
Table 54. AbbVie Autoimmune Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Johnson & Johnson Corporate Summary
Table 56. Johnson & Johnson Autoimmune Drugs Product Offerings
Table 57. Johnson & Johnson Autoimmune Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Biogen Corporate Summary
Table 59. Biogen Autoimmune Drugs Product Offerings
Table 60. Biogen Autoimmune Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Amgen Corporate Summary
Table 62. Amgen Autoimmune Drugs Product Offerings
Table 63. Amgen Autoimmune Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Pfizer Corporate Summary
Table 65. Pfizer Autoimmune Drugs Product Offerings
Table 66. Pfizer Autoimmune Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Roche Corporate Summary
Table 68. Roche Autoimmune Drugs Product Offerings
Table 69. Roche Autoimmune Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Baxter Corporate Summary
Table 71. Baxter Autoimmune Drugs Product Offerings
Table 72. Baxter Autoimmune Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Autoimmune Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 74. Global Autoimmune Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 75. Global Autoimmune Drugs Production by Region, 2017-2022 (K Units)
Table 76. Global Autoimmune Drugs Production by Region, 2023-2028 (K Units)
Table 77. Autoimmune Drugs Market Opportunities & Trends in Global Market
Table 78. Autoimmune Drugs Market Drivers in Global Market
Table 79. Autoimmune Drugs Market Restraints in Global Market
Table 80. Autoimmune Drugs Raw Materials
Table 81. Autoimmune Drugs Raw Materials Suppliers in Global Market
Table 82. Typical Autoimmune Drugs Downstream
Table 83. Autoimmune Drugs Downstream Clients in Global Market
Table 84. Autoimmune Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Autoimmune Drugs Segment by Type
Figure 2. Autoimmune Drugs Segment by Application
Figure 3. Global Autoimmune Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Autoimmune Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Autoimmune Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Autoimmune Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Autoimmune Drugs Revenue in 2021
Figure 9. By Type - Global Autoimmune Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Autoimmune Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Autoimmune Drugs Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Autoimmune Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Autoimmune Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Autoimmune Drugs Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Autoimmune Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Autoimmune Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Autoimmune Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Autoimmune Drugs Sales Market Share, 2017-2028
Figure 19. US Autoimmune Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Autoimmune Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Autoimmune Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Autoimmune Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Autoimmune Drugs Sales Market Share, 2017-2028
Figure 24. Germany Autoimmune Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Autoimmune Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Autoimmune Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Autoimmune Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Autoimmune Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Autoimmune Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Autoimmune Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Autoimmune Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Autoimmune Drugs Sales Market Share, 2017-2028
Figure 33. China Autoimmune Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Autoimmune Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Autoimmune Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Autoimmune Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Autoimmune Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Autoimmune Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Autoimmune Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Autoimmune Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Autoimmune Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Autoimmune Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Autoimmune Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Autoimmune Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Autoimmune Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Autoimmune Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Autoimmune Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Autoimmune Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Autoimmune Drugs by Region, 2021 VS 2028
Figure 50. Autoimmune Drugs Industry Value Chain
Figure 51. Marketing Channels
